UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.           )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐	Preliminary Proxy Statement	
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))	
☐	Definitive Proxy Statement	
☒	Definitive Additional Materials	
☐	Soliciting Material under §240.14a-12	
ACORDA THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒	No fee required.	
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.	
 	(1)	Title of each class of securities to which transaction applies:	

 	(2)	Aggregate number of securities to which transaction applies:	

 	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):	

 	(4)	Proposed maximum aggregate value of transaction:	

 	(5)	Total fee paid:	

☐	Fee paid previously with preliminary materials.	
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.	
 	(1)	Amount Previously Paid:	

 	(2)	Form, Schedule or Registration Statement No.:	

 	(3)	Filing Party:	

 	(4)	Date Filed:	

 

 
 
July 21, 2020
 
Dear Stockholder:
 
The Special Meeting of Stockholders of Acorda Therapeutics, Inc. is fast approaching, and according to our latest records, we have not received your vote. Your Board of Directors unanimously recommends that stockholders vote FOR all of the proposals on the agenda.
 
Approval of the Authorized Common Stock Increase Proposal and the Reverse Stock Split Proposal requires the affirmative vote of a majority of the outstanding shares.  THEREFORE, YOUR VOTE IS VERY IMPORTANT. To ensure your shares are represented at the Special Meeting, please vote TODAY--via the Internet or by telephone using the enclosed instructions, or alternatively by signing, dating and returning the enclosed voting instruction form or proxy card in the postage-paid envelope provided.
 
Thank you for your cooperation.
 
Very truly yours,

Andrew Mayer
Deputy General Counsel and Corporate Secretary

 

TIME IS SHORT!
 
Remember, you can vote your shares via the Internet or by telephone.
Please follow the instructions on the enclosed voting instruction form
or proxy card to cast your vote.
 
If you have any questions, or need assistance in voting
your shares, please call our proxy solicitor:
 
INNISFREE M&A INCORPORATED
TOLL-FREE, at 1-877-717-3929